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Abstract: The hypothalamic paraventricular nucleus (PVN) regulates
numerous homeostatic systems and functions largely under the influence of
forebrain inputs. Glutamate is a major neurotransmitter in forebrain, and
glutamate neurosignaling in the PVN is known to mediate many of its
functions. Previous work showed that vesicular glutamate transporters
(VGluTs; specific markers for glutamatergic neurons) are expressed in
forebrain sites that project to the PVN; however, the extent of this presumed
glutamatergic innervation to the PVN is not clear. In the present study
retrograde FluoroGold (FG) labeling of PVN-projecting neurons was combined
with in situ hybridization for VGluT1 and VGluT2 mRNAs to identify forebrain
regions that provide glutamatergic innervation to the PVN and its immediate
surround in rats, with special consideration for the sources to the anterior
versus posterior PVN. VGluT1 mRNA colocalization with retrogradely labeled
FG neurons was sparse.
VGluT2 mRNA colocalization with FG neurons was most abundant in
the ventromedial hypothalamus after anterior PVN FG injections, and in the
lateral, posterior, dorsomedial, and ventromedial hypothalamic nuclei after
posterior PVN injections. Anterograde tract tracing combined with VGluT2
immunolabeling showed that 1) ventromedial nucleus-derived glutamatergic
inputs occur in both the anterior and posterior PVN; 2) posterior nucleusderived glutamatergic inputs occur predominantly in the posterior PVN; and
3) medial preoptic nucleus-derived inputs to the PVN are not glutamatergic,
thereby corroborating the innervation pattern seen with retrograde tracing.
The results suggest that PVN subregions are influenced by varying amounts
and sources of forebrain glutamatergic regulation, consistent with functional
differentiation of glutamate projections.
INDEXING TERMS: vesicular glutamate transporter, FluoroGold, retrograde
labeling, Phaseolus vulgaris leucoagglutinin, anterograde labeling

The paraventricular nucleus of the hypothalamus (PVN) plays a
role in regulating body temperature, sexual function, lactation, food
intake, energy balance, water/osmotic balance, and the activities of
the hypothalamic–pituitary–adrenocortical axis and the autonomic
nervous system (Bisset and Chowdrey, 1988; McKenna, 2001; Nagy et
al., 2005; Schlenker, 2005). The PVN is under the control of
forebrain/limbic inputs (Herman et al., 2003; Fehm et al., 2006;
Lechan and Fekete, 2006), many of which use glutamate as the
principal excitatory neurotransmitter. The PVN is heavily innervated by
glutamatergic fibers (van den Pol, 1991; Wittmann et al., 2005;
Ziegler et al., 2005) and PVN neurons express several types of
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glutamate receptors (Aubry et al., 1996; Mateos et al., 1998; Herman
et al., 2000; Eyigor et al., 2005; Ziegler et al., 2005), suggesting that
glutamate is an important neurotransmitter in this region. A prominent
role for glutamate signaling in the PVN is supported by studies
indicating excitatory effects of glutamate on hypothalamic–pituitary–
adrenocortical axis activity (Ziegler and Herman, 2000), sympathetic
tone (Badoer et al., 2003; Freeman and Brooks, 2007), sexual
behavior (Melis et al., 2004), suckling-induced prolactin release (Nagy
et al., 2005), and food intake (Hettes et al., 2003). Collectively, this
work suggests that glutamatergic inputs from the forebrain are critical
regulators of PVN functions.
The specific forebrain origins of glutamatergic innervation to the
PVN are not clear. Interpretation of previous work addressing this
question is made difficult by the paucity of specific markers for
glutamatergic neurons (e.g., all cells contain some glutamate as a part
of normal cellular metabolism). Definitive identification of glutamate
neurons has only become possible with the recent cloning of vesicular
glutamate transporters, which specifically package glutamate into
synaptic vesicles.
Therefore, the present work combines tract tracing with
phenotypic markers of glutamate neurons to determine glutamate
inputs to the PVN. The retrograde tracing approach uses expression of
vesicular glutamate transporter 1 (VGluT1) and 2 (VGluT2) mRNAs as
specific markers of glutamatergic neurons (reviewed in Ziegler et al.,
2002; Takamori, 2006) combined with retrograde FluoroGold (FG)
labeling of PVN-projecting neurons to identify forebrain regions that
provide glutamatergic innervation to the PVN and its surround, with
special consideration for the sources of innervation to the anterior
versus posterior PVN. Given the paucity of VGluT1 mRNA expression in
forebrain regions that project directly to the PVN (Kaneko and
Fujiyama, 2002; Ziegler et al., 2002; Collin et al., 2003), we
hypothesized that PVN-projecting glutamatergic neurons would be
characterized primarily by the expression of VGluT2 mRNA. Moreover,
we hypothesized that established PVN-projecting forebrain sites with
known expression of VGluT2 mRNA (Ziegler et al., 2002; Collin et al.,
2003; Lin et al., 2003), such as the ventromedial hypothalamic
nucleus, dorsomedial hypothalamic nucleus, lateral hypothalamic area,
and posterior hypothalamus nucleus, would be the primary sources of
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glutamatergic innervation to the PVN. In addition, to corroborate
projections identified by retrograde tracing studies, anterograde
tracing with Phaseolus vulgaris leucoagglutinin (PhaL) was combined
with immunolabeling for VGluT2 to determine the extent to which
various regions provide glutamatergic inputs to the PVN.

Materials and Methods
Experimental animals
Adult, male, Sprague–Dawley rats (250–350 g; Harlan,
Indianapolis, IN) were used. Rats arrived at least 1 week prior to the
onset of experiments and were housed on a 12-hour light/dark cycle
(06:00–18:00) with ad libitum access to normal rat chow and water in
a constant temperature-humidity vivarium. All procedures were
approved by the University of Cincinnati Animal Care and Use
Committee.

FluoroGold injections
Experiments used retrograde labeling of FG targeted to the PVN
to identify PVN-projecting neurons. Rats were anesthetized
(intraperitoneally [i.p.]) with a mixture of ketamine (95 mg/kg body
weight) and xylazine (12.5 mg/ kg body weight) and then placed into
a Kopf (Tujunga, CA) stereotaxic apparatus. Surgical procedures
employed aseptic technique. FG (2% in saline vehicle; Fluorochrome,
Denver, CO) was backfilled into a glass micropipette with a tip
diameter of 10–15 µm. The micropipette was slowly inserted
unilaterally into the PVN (from bregma AP −1.5 mm, ML −0.4 mm,
and DV −6.65 mm from dura). FG was iontophoretically injected using
an intermittent current (2–4 μA with 7 seconds on/off for ≈30
seconds). The micropipette was then slowly raised, the skull hole was
filled with bone wax, and the skin incision was wound-clipped.
Following ≈7–10 days recovery, rats were given sodium
pentobarbital overdose (150 mg/kg body weight) and perfused with
4% paraformaldehyde in sodium phosphate-buffered saline (NaPBS,
0.1 M, pH 7.4). The brains were removed and placed in vials with 4%
paraformaldehyde in PBS overnight, followed by placement into 30%
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sucrose at 4°C. Coronal microtome sections (25 µm thick) were cut
through the brain, placed into cryoprotective solution (30% sucrose,
w/v; 1% polyvinlypyrrolidone [PVP-40], w/v; 30% ethylene glycol,
v/v; in 50 mM sodium phosphate buffer, pH 7.4), and were stored at
−20°C until use.

Preparation of vesicular glutamate transporter cRNA
probes
In situ hybridization for VGluT1 and VGluT2 mRNAs was used to
specifically identify these two classes of glutamatergic neurons (Ziegler
et al., 2002). Antisense cRNA probes complementary to VGluT1
(1666–1976 bp of Access no. NM_053859.1) and VGluT2 (1972–2437
bp of Access. no. NM_053427.1) were generated by in vitro
transcription using 35S-UTP, as described previously (Ziegler et al.,
2002). The VGluT1 and VGluT2 fragments were each cloned into a
pGEM-T Easy plasmid vector, linearized with PvuII (VGluT1) or StyI
(VGluT2), and transcribed with T7 (VGluT1) or SP6 (VGluT2) RNA
polymerases.

In situ hybridization combined with FG
immunocytochemistry
Prior to hybridization, a 1-in-6 series of sections was washed
with 50 mM NaPBS and incubated in blocking buffer (0.3% TX-100 and
0.2% bovine serum albumin [BSA] in NaPBS). Sections were
hybridized overnight at 45°C with 4.5 × 106 cpm 35S labeled probe/5
mL/well, diluted in hybridization medium (50% formamide, 20 mM
Tris-HCl, pH 7.5, 1 mM EDTA, 335 mM sodium chloride, 1 ×
Denhardt’s, 200 µg/mL salmon sperm DNA, 25 µg/ mL yeast tRNA, 20
mM dithiothreitol, and 10% dextran sulfate). Tissue sections were then
rinsed in 2× SSC buffer (1 × SSC = 0.25 M sodium chloride, 0.015 M
sodium citrate, pH 7.2) and treated with RNAse A (200 µg/ mL) for 3
hours at 37°C. Sections were washed in 2× SSC, 1× SSC, and 0.5 ×
SSC at room temperature and incubated for 1 hour at 45°C in 0.5×
SSC. Following incubation in blocking buffer at room temperature, the
sections were placed into primary antibody directed against FG
(1:5,000 in blocking buffer; kindly provided by Dr. Stanley Watson,
University of Michigan; Table 1) overnight at 4°C. The sections were
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washed with 50 mM potassium phosphate buffered saline (KPBS),
0.02% TX-100, and then incubated with affinity-purified biotinylated
anti-rabbit immunoglobulin G (IgG) made in goat (1:500 in 50 mM
KPBS, 0.02% TX-100; Vector Laboratories, Burlingame, CA). After
incubation the sections were washed in 50 mM KPBS, 0.02% TX-100,
and incubated in Vectastain ABC Solution (1:1,000 in 50 mM KPBS,
0.1% BSA; Vector Laboratories). After incubation the sections were
washed in 50 mM KPBS/0.02% TX-100 and visualized by exposure to
3,3’-diaminobenzidine (DAB; 0.4 mg/mL in 50 mM KPBS/0.005%
hydrogen peroxide). FG was visualized by chromagen reaction to
provide a stable signal for detection of colocalization in emulsiondipped sections. Following rinsing the sections were mounted onto
glass slides that were subsequently coated with Kodak photographic
emulsion NTB2 (diluted 1:1 with water), air-dried, and stored at 4°C in
a light- and humid-free environment for 4 weeks. Following
development in Kodak D-19 developer and Rapid Fix solutions,
emulsion-dipped sections were dehydrated through a series of graded
ethanol, cleared with xylene, and coverslipped using DPX mountant
(Fluka, Milwaukee, WI).

PhaL injections and immunohistochemistry
Iontophoretic injection of the anterograde tract tracer PhaL into
the ventromedial, posterior, and medial preoptic hypothalamic nuclei,
with subsequent visualization of boutons coimmunolabeled for PhaL
and VGluT2 in the PVN, was employed to independently determine
whether the PVN receives differential VGluT2-positive innervation from
these regions along its rostral-caudal extent. Injections of PhaL (2.5%
in 10 mM phosphate buffer, pH 8.0; Vector Laboratories) were
performed as described above for FG with the following exceptions.
First, the unilateral injections were targeted to either the ventromedial
nucleus (from bregma AP −2.6 mm, ML 0.6 mm, and DV −9.0 to −9.4
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mm from dura), the posterior nucleus (from bregma AP −3.8 mm, ML
0.5 mm, and DV −7.3 to −7.7 mm from dura), or the medial preoptic
nucleus (from bregma AP−0.8 mm, ML 0.45 mm, and DV −8.4 to −8.8
mm from dura). Second, the micropipette tip had a diameter of 20–25
µm and the PhaL was injected using a 5 μA intermittent current (7
seconds on/off) for 15 minutes.
Following 7–10 days recovery the rats were perfused and the
brains were collected and sectioned as described above. For single
immunolabeling of PhaL, tissue sections were rinsed in KPBS,
incubated in 1% hydrogen peroxide (10 minutes), rinsed, and then
incubated in blocking buffer (50 mM KPBS, 0.1% BSA, and 0.2% TX100) for 1 hour at room temperature. Sections were placed into goat
anti-PhaL primary antibody (1:3,000 in blocking buffer; Vector
Laboratories; product #AS-2224, lot #N0712) overnight at 4°C.
Following incubation the sections were rinsed and placed into affinitypurified biotinylated horse antigoat IgG (1:500 in 50 mM KPBS/0.01%
BSA; Vector Laboratories) for 1 hour. Sections were rinsed again and
placed into Vectastain ABC Solution (1:1,000 in 50 mM KPBS/0.1%
BSA; Vector Laboratories) for 1 hour. After rinsing, sections were
stained with DAB (as described above), rinsed, mounted onto slides,
dehydrated through a graded series of ethanol, cleared with xylene,
and coverslipped with DPX mountant. Dual immunolabeling of PhaL
and VGluT2 was performed as described above, except 1) rabbit antiVGluT2 antibody (1:500; Synaptic Systems, Gottingen, Germany,
product #135 402, lot 135402/12) was added to the anti-PhaL primary
antibody incubation; and 2) immunolabeling was visualized using
Alexa488-conjugated donkey antigoat IgG (1:500; Invitrogen, La Jolla,
CA; product #A11055, lot 645148) and Cy3-conjugated affinity
purified donkey antirabbit IgG (1:500; Jackson ImmunoResearch Labs,
West Grove, PA; product #711-165-152, lot 88464).

Antibody characterization
The anti-FG primary antiserum was generated against the FG
molecule. The efficacy of the FG antiserum was verified by dual
fluorescence imaging, demonstrating complete overlap between native
FG fluorescence and immunofluorescence following incubation of
sections with anti-FG.
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The specificity of the PhaL immunolabeling was verified by a
lack of labeling 1) with omission of the primary antibody; 2) with
preabsorption of the primary antibody with PhaL; and 3) in tissues that
had not been injected with PhaL.
The anti-VGluT2 primary antiserum recognizes a single 65-kDA
band in brain tissue corresponding to the molecular weight predicted
for VGluT2, and VGluT2 labeling is lost following omission of the
primary antiserum or preabsorption of the antiserum with the
immunizing peptide (Zhou et al., 2007; Graziano et al., 2008). VGluT2
immunoreactivity was specifically localized in brain regions known to
receive projections from areas containing dense VGluT2 mRNA
expression, and the labeling did not correspond with patterns of
staining seen using antibodies against VGluT1 (Flak et al., 2009).

Image analysis
Anatomical regions of interest were defined using the Paxinos
and Watson (1998) and Swanson (1998) rat brain atlases. Anatomical
mapping was performed by viewing material under both brightfield and
darkfield microscopy to define anatomical landmarks, including 1) the
location and size of the white matter tracts (e.g., fornix, optic tract,
etc.) and ventricles; 2) variations in cellular density (e.g., compact
zone of dorsomedial hypothalamic nucleus); and 3) variations in the
density of VGluT mRNA labeling (e.g., VGluT2 mRNA in the
ventromedial hypothalamus). For the bed nucleus of the stria
terminalis, the anterodorsal subdivision refers to the entire portion
that is dorsal to the crossing of the anterior commissure at that
rostral-caudal level, whereas the anteroventral subdivision refers to
the entire portion that is ventral to the crossing of the anterior
commissure at that rostral-caudal level. Sections were imaged using
either an Axioplan 2 microscope (Zeiss, Thornwood, NY) equipped with
an imaging system (Axiocam camera and AxioVision release 4.4
software; Zeiss) or an AxioImager.Z1 microscope (Zeiss) equipped
with apotome (z-stack) imaging capability (Axiocam MRm camera and
AxioVision Release 4.6 software; Zeiss).
Cell counts were performed for the identified anatomical regions
at all rostral-caudal levels as they appeared in the evenly spaced, 1-in6 series of tissue sections. The reported cell counts were not corrected
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for sampling interval. Since the FG injection sites included different
proportions of the PVN, the location of the retrogradely labeled
neurons varied across the individual cases. In addition, retrogradely
labeled cells varied widely in size, shape, and distribution, making it
impossible to generate valid estimates of the mean cell diameter.
Hence, uncorrected raw profile counts for individual animals are given,
without an attempt to correct them for cell size. We recognize that the
larger cells will be somewhat overrepresented in these samples.
Criterion for identification of FG-immunoreactive cells was a clearly
visible DAB reaction product in the shape of a neuronal cell body, often
including neuronal processes. Dual-labeled cells were defined as FGimmunoreactive cells overlain by grain densities 5 times that of an
equivalent background area (i.e., an adjacent region containing fiber
tracts). The number of cells positive for FG only (DAB-positive) and
those doublepositive for FG and VGluT mRNA were counted throughout
forebrain. Subsequent analyses focused on brain regions that
consistently contained at least 10 FG-positive cells from either the
anterior PVN, posterior PVN, or both, reasoning that these brain
regions likely represent the primary sources of significant
glutamatergic innervation to the PVN and its surround. For the PhaL
anterograde analysis, dual fluorescence immunolabeling was imaged
throughout the rostral-caudal extent of the PVN via apotome z-stack
images (each optical section of z-stack had a thickness of ≈0.45µm)
and the relative prevalence of dual-labeled boutons was noted. For
clarity of presentation (Figs. 1, ,2,2, ,44–6), image contrast and
brightness were adjusted using Adobe Photoshop 7.0 (San Jose, CA).
In addition, the dodge and burn tools in Adobe Photoshop 7.0 were
used in some of the low-magnification brightfield images (Figs. 4–6) to
correct for uneven illumination.
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Figure 1

FG-injection sites into the PVN and its surround showed varying

involvement along the rostral-to-caudal extent of the nucleus. The anterior-to-mid
portions of the PVN were primarily involved in cases 90 (≈bregma −1.4 mm for left
and middle; ≈bregma −1.8 mm for right), 110 (≈bregma −1.3 mm for left and
middle; ≈bregma −1.8 mm for right), and 112 (≈bregma −1.4 mm for left and
middle; ≈bregma −1.8 mm for right), whereas the mid-to-posterior portions of the
PVN were primarily involved in cases 102 (≈bregma −2.12 mm for left and middle;
≈bregma −1.8 mm for right), 104 (≈bregma −2.12 mm for left and middle; ≈bregma
−1.8 mm for right), and 109 (≈bregma −2.12 mm for left and middle; ≈bregma −1.8
mm for right). Injection sites were imaged using brightfield microscopy (left) and were
mapped onto schematics (middle and right) modified from the Paxinos and Watson
atlas (1998), following immunolabeling for FG with DAB visualization. Scale bars =
200 µ.m.
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Figure 2

Representative examples of cellular labeling for FG and vescicular

glutamate transporter mRNA. A: Two FG-positive cells in the medial preoptic area; no
other DAB labeling in the image reached criterion for quantification as an FG-positive
neuron (asterisk). B: Focusing on the silver grains (black dots) that overlie the cells in
panel A shows that one FG-positive cell is also positive for VGluT1 mRNA (arrow),
whereas the other is not (arrowhead). Cells that colabeled for FG and VGluT1 mRNA
were rarely observed in any of the examined brain regions. C: Two FG-positive cells in
the ventromedial hypothalamic nucleus; no other DAB labeling in the image reached
criterion for quantification as an FG-positive neuron (asterisk). D: Focusing on the
silver grains (black dots) that overlie the cells in panel C shows that one FG-positive
cell is also positive for VGluT2 mRNA (arrow), whereas the other is not (arrowhead).
Also note that the background leve of hybridization was higher for VGluT1, so more
silver grains (5× background) were required for a cell to be considered VGluT1positive. Scale bars = 20 µm.
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Figure 4

PhaL injections into the ventromedial hypothalamic nucleus produced

more anterogradely labeled fibers in the anterior than posterior PVN. A: Diagram (left)
and brightfield image (right) depicting the location of a PhaL injection site in the
ventromedial nucleus (case 15; ≈bregma −2.8 mm). B: Brightfield image shows
numerous PhaL-positive fibers and boutons in the anterior PVN (≈bregma −0.8 mm)
and its surround. C: At the level of mid PVN (≈bregma −1.8 mm), few PhaL fibers and
boutons are seen in the parvocellular subdivision with even less in the magnocellular
subdivision; some PhaL-positive fibers occur in the PVN surround. D: In the posterior
PVN (≈bregma −2.1 mm), there are few PhaL-positive fibers and boutons in the
medial portion and even fewer in the lateral portion, with numerous PhaL-positive
fibers occurring ventrally in the PVN surround (i.e., sub-PVN). Dual immunolabeling for
PhaL (green) and VGluT2 (magenta) shows a greater density of PhaL-positive fibers
and boutons in anterior (E) versus posterior (F) PVN, with relatively comparable levels
of VGluT2 labeling (images are projections made from z-stack images). In the anterior
PVN, higher magnification views of a single optical section (≈0.45 µm thick) show a
PhaL-positive bouton (arrow; G) that is also positive for VGluT2 (arrow; H,I; dual
labeling appears white). In the posterior PVN, higher magnification views of a single
optical section (≈0.45 µm thick) show three PhaL-positive boutons (arrows; J) that are
also positive for VGluT2 (arrows; K,L). Diagram in (A) modified from Paxinos and
Watson (1998). Scale bars = 200 µm for A–D; 20 µm for E,F; 5 µm for G–I; 10 µm for
J–L.
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Figure 6

PhaL injections into the medial preoptic hypothalamic nucleus produced

more anterogradely labeled fibers in the anterior than posterior PVN. A: Diagram (left)
and brightfield image (right) depicting the location of a PhaL injection site in the
medial preoptic nucleus (case 20; ≈bregma −0.8 mm). B: Brightfield image shows
numerous PhaL-positive fibers and boutons in the anterior PVN (≈bregma −0.8 mm)
and its surround. C: At the level of mid PVN (≈bregma −1.8 mm), few PhaL fibers and
boutons are seen in the parvocellular subdivision with even less in the magnocellular
subdivision; some PhaL-positive fibers occur in the PVN surround. D: In the posterior
PVN (≈bregma −2.1 mm), there are few PhaL-positive fibers and boutons in the
medial portion and even fewer in the lateral portion, with some PhaL-positive fibers
occurring in the PVN surround. Dual immunolabeling for PhaL (green) and VGluT2
(magenta) shows a greater density of PhaL-positive fibers and boutons in anterior (E)
versus posterior (F) PVN, with relatively comparable levels of VGluT2 labeling (images
are projections made from z-stack images). In the anterior PVN, higher magnification
views of a single optical section (≈0.48 µm thick) show a PhaL-positive bouton (G)
that is not positive for VGluT2 (H,I). In the posterior PVN, higher magnification views
of a single optical section (≈0.41 µm thick) show a PhaL-positive bouton (J) that is not
positive for VGluT2 (K,L); dual labeled boutons were not observed in either the
anterior or posterior PVN. Diagram in (A) modified from Paxinos and Watson (1998).
Scale bars = 200 µm for A–D; 10 µm for E,F; 5 µm for G–L.
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Results
FG injection sites and forebrain retrograde labeling
There were six cases in which the FG injection involved the PVN
with minimal spread into adjacent structures; these cases varied in the
degree of rostral-to-caudal involvement of the PVN (Fig. 1). The FG
injection in case 90 included most of the anterior PVN (e.g., bregma
−1.4 mm) with a small amount in the dorsal-most portion of the PVN
at more caudal levels. Adjacent structures that contained some FG
included the peri-PVN, nucleus reuniens, and medial tip of the zona
incerta. In case 110 the FG injection site filled the anterior PVN (e.g.,
bregma − 1.0 and −1.4 mm) and hit the dorsal edge of the PVN at
mid-PVN levels (e.g., bregma −1.8 mm). This case had minimal FG
spread into the peri-PVN and nucleus reuniens. In case 112 the FG site
involved almost the entirety of the PVN at anterior (e.g., bregma −1.3
mm) and mid-PVN levels (e.g., bregma −1.7 mm). There was little FG
spread into the peri-PVN and medial preoptic area/ nucleus. The FG
injection site in case 102 included much of the posterior PVN (bregma
−2.1 mm) and hit the dorsal edge of the PVN at mid-PVN levels (e.g.,
bregma −1.8 mm), as well as small amounts into the peri-PVN,
anterior hypothalamic nucleus posterior subdivision, and medial tip of
the zona incerta. The FG injection site in case 104 included much of
the posterior PVN (bregma −2.1 mm) and hit the dorsal edge of the
PVN at mid-PVN levels (e.g., bregma −1.8 mm), with small amounts
into the nucleus reuniens and the medial tip of the zona incerta. In
case 109 the FG site involved the medial portion of the PVN at mid(bregma −1.8 mm) and posterior- (bregma −2.1 mm) PVN levels with
some FG spread into the contralateral medial PVN, the nucleus
reuniens, and the medial tip of the zona incerta. An initial analysis
indicated that in several forebrain regions the number of retrogradely
labeled FG cells varied with the rostral-to-caudal extent of the FG
injection site in the PVN. Therefore, subsequent analyses were
conducted by dividing the cases into two groups: those that involved
the anterior-to-mid PVN (cases 90, 110, and 112) and those that
involved the mid-to-posterior PVN (cases 102, 104, and 109), with
mid-PVN being defined as approximately bregma −1.8 mm, using the
Paxinos and Watson coordinate system (1998).
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Forebrain regions that contained substantial numbers of
retrogradely labeled FG-positive cells (on average >10 from anterior
and/or posterior PVN) are listed in Table 2, and include regions in the
bed nucleus of the stria terminalis, hypothalamus, and thalamus. It
should be noted that in addition to the cell counts presented on Table
2, a few FG-positive cells (on average <5 per region) were
occasionally observed in the nucleus of the diagonal band and
subregions of the amygdala (e.g., central and cortical), thalamus (e.g.,
reticular, and parataenial) and hypothalamus (e.g., anterodorsal
preoptic nucleus, anteroventral preoptic nucleus, supraoptic nucleus,
and the anterior part of the ventromedial nucleus; for abbreviations,
see Table 3), but the low incidence in these regions precluded further
quantification of VGluT colocalization. Low numbers of FG-positive cells
were commonly observed in the subfornical area and organum
vasculosum of the lamina terminalis and many of these appeared to be
VGluT2-positive; however, the low prevalence precluded further
quantification. Similarly, low numbers of FG-positive cells were
occasionally observed in the anterior PVN following FG injections
targeted to the posterior PVN but the low prevalence precluded
quantification.
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VGluT1 and VGluT2 mRNA expression
Robust expression of VGluT1 mRNA was observed in the
cerebral cortex, hippocampus, medial habenula, and lateral amygdala,
as previously noted (Ziegler et al., 2002). Weaker VGluT1 mRNA
hybridization signal (diffuse labeling) was observed in hypothalamic
nuclei, including the PVN and supraoptic nucleus. Only a few doublelabeled FG/VGluT1-positive neurons (Fig. 2) were observed in the
forebrain, and the frequency of these neurons was too low to permit
quantification.
VGluT2 mRNA was highly expressed in the habenula (medial and
lateral), thalamus, and hypothalamus, including the ventromedial
hypothalamic nucleus, anteroventral periventricular nucleus, preoptic
nuclei, dorsomedial hypothalamic nucleus, posterior hypothalamic
nucleus, lateral hypothalamic area, and mammillary nuclei, as noted
previously (Ziegler et al., 2002). More moderate expression of VGluT2
mRNA was noted in portions of the medial amygdala, substantia
innominata, bed nucleus of the stria terminalis, zona incerta, anterior
hypothalamic nucleus, tuberal nucleus, and retrochiasmatic area, often
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limited to scattered cells. By comparison, the PVN and supraoptic
nucleus expressed low levels of VGluT2 mRNA (diffuse labeling lacking
cellular resolution). Numerous double-labeled FG/VGluT2-positive
neurons (Fig. 2) were observed throughout forebrain, with some
notable variations depending on the rostral-to-caudal extent of the FG
injection site in the PVN. Therefore, subsequent results are presented
divided into two groups: FG injection sites in anterior-to-mid PVN
versus in mid-to-posterior PVN.

VGlut2-innervation to anterior PVN
Following FG injection in the anterior PVN and its surround
(Table 2; Fig. 3), high numbers of FG-positive cell bodies were
observed ipsilaterally in the anterior hypothalamic area and nucleus,
lateral hypothalamic area, medial preoptic area and nucleus,
ventromedial hypothalamic nucleus, medial amygdala, and zona
incerta. Among these regions, only the ventromedial hypothalamic
nucleus represented a primary source of VGluT2-positive innervation,
with ≈25% of the FG-labeled cells colabeling for VGluT2.

Figure 3

FG injections into the anterior versus posterior PVN and its surround

reveal differing extents of VGluT2 mRNA colocalization in PVN-projecting brain regions.
Case 110 (anterior-to-mid PVN injection) is shown on the left side of the brain
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illustrations (open circles denote cells that are positive for FG only, whereas filled
circles denote cells that are dual positive for FG and VGluT2 mRNA). Case 102
(posterior-to-mid PVN injection) is shown on the right side of the brain illustrations
(open triangles denote cells that are positive for FG only, whereas filled triangles
denote cells that are dual positive for FG and VGluT2 mRNA). A: ≈Bregma −0.4 mm.
B: ≈Bregma −0.5 mm. C: ≈Bregma −1.55 mm. D: ≈Bregma −1.8 mm. E: ≈Bregma
−2.8 mm. F: ≈Bregma −3.3 mm. Approximate cell locations were mapped onto
schematics modified from the Swanson atlas (1998).

More moderate numbers of FG-positive cell bodies were found
ipsilaterally in the bed nucleus of the stria terminals (anterodorsal,
anteroventral, interfascicular/ventral, and principle subdivisions),
arcuate nucleus, dorsomedial hypothalamic nucleus, lateral preoptic
area, median preoptic area, posterior hypothalamic nucleus,
periventricular hypothalamic nucleus, retrochiasmatic area,
suprachiasmatic nucleus, tuberal nucleus, paraventricular thalamic
nucleus, lateral septum, and substantia innominata after injection in
the anterior PVN and its surround. These regions generally contributed
little-to-no VGluT2-positive innervation to the anterior PVN and its
surround (less than 15% colocalization).
Contralateral to the FG injection site (data not shown), the
pattern of FG-positive cell labeling was generally similar to that
observed ipsilaterally; however, the total number of FG-positive cells
in each region was substantially lower. Moreover, FG coexpression with
VGluT2 was low throughout contralateral forebrain (less than 15%).

VGlut2-innervation to posterior PVN
FG injection into the posterior PVN and its surround (Table 2;
Fig. 3) produced high numbers of FG-positive cell bodies in the
anterior hypothalamic nucleus, lateral hypothalamic nucleus, posterior
hypothalamic nucleus, ventromedial hypothalamic nucleus, lateral
septum, and zona incerta. Of these regions, the ventromedial
hypothalamic nucleus and posterior hypothalamic nucleus were major
sources of VGluT2 innervation to the posterior PVN, with ≈80% and
60% colocalization, respectively. The anterior hypothalamic nucleus
and lateral hypothalamic area also contributed VGluT2 innervation,
with ≈25% colocalization. In contrast, the lateral septum and zona
incerta contributed little-to-no VGluT2 innervation to the posterior PVN
and its surround (less than 5% colocalization).
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More moderate numbers of FG-positive cells were consistently
located in the bed nucleus of the stria terminalis (anteroventral and
interfascicular/ventral subdivisions), dorsomedial hypothalamic
nucleus, lateral preoptic area, medial preoptic area and nucleus,
paraventricular thalamic nucleus, medial amygdala, and substantia
innominata following FG injection into the posterior PVN and its
surround. Among these regions a large proportion of the FG-positive
cells coexpressed VGluT2 in the paraventricular thalamic nucleus
(≈80%), medial amygdala (≈50%), and dorsomedial hypothalamic
nucleus (≈40%). Significantly fewer FG-positive cells colabeled for
VGluT2 in the bed nucleus of the stria terminalis, lateral preoptic area,
medial preoptic area and nucleus, and substantia innominata
(generally no more than 15% colocalization).
Contralateral to the FG injection site (data not shown), the
pattern of FG-positive cell labeling was generally similar to that
observed ipsilaterally; however, the total number of FG-positive cells
in each region was reduced. Moreover, FG coexpression with VGluT2
was still high in the contralateral ventromedial hypothalamic nucleus
(≈80%), paraventricular thalamic nucleus (80%), and posterior
hypothalamus (≈70%); moderate in the anterior hypothalamic nucleus
(25%), lateral hypothalamic area (25%), medial amygdala (35%), and
dorsomedial hypothalamic nucleus (40%); and low in the bed nucleus
of the stria terminalis, lateral preoptic area, medial preoptic area and
nucleus, lateral septum, substantia innominata, and zona incerta
(generally less than 15%).

Anterograde PhaL labeling from ventromedial nucleus
to PVN
Three cases (11, 13, and 15) contained PhaL injection sites in
the ventromedial nucleus. In case 11 the PhaL site involved the
dorsomedial subdivision, central subdivision, and the dorsal portion of
the ventrolateral subdivision, with only minimal spread dorsally into
the dorsomedial hypothalamic nucleus. The PhaL injection site in case
13 included the lateral portions of the dorsomedial and central
subdivision and the dorsal portion of the ventrolateral subdivision, with
minimal lateral spread into the lateral hypothalamic area. The PhaL
injection site in case 15 included the dorsomedial subdivision, the
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medial portion of the central subdivision, and the mediodorsal portion
of the ventrolateral subdivision, with minimal spread beyond the
ventromedial nucleus. The PhaL labeling produced in the PVN was
similar for all three cases; representative images from cases 13 and 15
are shown in Figure 4. The anterior PVN contained numerous PhaLpositive fibers and boutons throughout the nucleus. The posterior PVN
showed few PhaL-positive fibers and the mid-PVN contained an
intermediate amount; at theses levels PhaL-positive fibers and boutons
were present only in the medial (e.g., parvocellular) portions of the
nucleus. Dual immunolabeling for PhaL and VGluT2 showed that while
the posterior PVN contains a relatively small number of PhaL-positive
boutons, most colabel with VGluT2 immunoreactivity (Fig. 4F,J,K,L). In
contrast, the anterior PVN receives a richer innervation of PhaLpositive fibers and boutons, and while several colabel for VGluT2 there
are also numerous PhaL fibers with boutons that do not colabel,
suggesting other neurotransmitter phenotypes (Fig. 4E,G–I).

Anterograde PhaL labeling from posterior hypothalamic
nucleus to PVN
Two cases (8 and 10) contained PhaL injection sites targeted to
the posterior hypothalamic nucleus. The PhaL injection site in case 8
was located in the dorsal portion of the posterior nucleus with minimal
spread beyond the nucleus. In case 10 the PhaL injection site was
similarly located but with a bit of spread dorsal to the nucleus. The
PhaL labeling produced in the PVN was similar for both cases;
representative images from case 8 are shown in Figure 5. The anterior
PVN (≈bregma −0.8 mm) contained few PhaL-positive fibers and
boutons, whereas mid PVN (≈bregma −1.8 mm) contained several
PhaL-positive fibers and boutons, particularly in the parvocellular
subdivision. In the posterior PVN (≈bregma −2.1 mm) there were
numerous PhaL-positive fibers and boutons throughout the PVN.
Moreover, PhaL-positive fibers were most dense in the PVN surround
at the mid and posterior levels. Boutons dual-labeled for PhaL and
VGluT2 were rarely observed in the anterior PVN, but commonly
observed in the posterior PVN.
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Figure 5

PhaL injections into the posterior hypothalamic nucleus produced more

anterogradely labeled fibers in the posterior than anterior PVN. A: Diagram (left) and
brightfield image (right) depicting the location of a PhaL injection site in the posterior
nucleus (case 8; ≈bregma −3.8 mm). B: Brightfield image shows few PhaL-positive
fibers and boutons in the anterior PVN (≈bregma −0.8 mm). C: At the evel of mid PVN
(≈bregma −1.8 mm), many PhaL fibers and boutons are seen in the parvocellular
subdivision with less in the magnocelular subdivision; the greatest density of PhaLpositive fibers occurs in the PVN surround. D: In the posterior PVN (≈bregma −2.1
mm), there are numerous PhaL-positive fibers and boutons throughout the PVN and an
even greater fiber density in the PVN surround. Dual immunolabeling for PhaL (green)
and VGluT2 (magenta) shows a lower density of PhaL-positive fibers and boutons in
anterior (E) versus posterior (F) PVN, with relatively comparable levels of VGluT2
labeling (images are projections made from z-stack images). In the anterior PVN,
higher magnification views of a single optical section (≈0.45 µ.m thick) show a rare
PhaL-positive bouton (arrow; G) that is also positive for VGluT2 (arrow; H,I). In the
posterior PVN, higher magnification views of a single optical section (≈0.45 µm thick)
show two PhaLpositive boutons (arrows; J) that are also positive for VGluT2 (arrows;
K,L; dual labeling appears white); dual-labeled boutons are much more commonly
observed in the posterior versus anterior PVN. Diagram in (A) modified from Paxinos
and Watson (1998). Scale bars = 200 µm for A–D; 20 µm for E,F; 5 µm for G–L.

Anterograde PhaL labeling from medial preoptic
hypothalamic nucleus to PVN
Two cases (18 and 20) contained PhaL injection sites targeted
to the medial preoptic hypothalamic nucleus. The PhaL injection site in
case 18 was located in the rostral portion of the medial preoptic
nucleus, with minimal spread beyond the nucleus. In case 20 the PhaL
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injection site included the lateral subdivision, central subdivision, and
lateral portion of the medial subdivision, with minimal spread into the
lateral hypothalamic area. The PhaL labeling produced in the PVN was
similar for both cases; representative images from case 20 are shown
in Figure 6. The anterior PVN (≈bregma −0.8 mm) contained
numerous PhaL-positive fibers and boutons, with even higher levels in
the PVN surround. Mid and posterior PVN had few PhaL fibers in the
medial portions of the nucleus, with even less in the lateral PVN.
Notably, boutons dual labeled for PhaL and VGluT2 were not observed
in the PVN regardless of rostral-caudal level.

Discussion
Sources of forebrain glutamatergic innervation to the PVN and
its surround were determined by combining retrograde FG labeling
from the PVN with in situ hybridization for VGluT1 and VGluT2 mRNA.
VGluT1 mRNA was highly expressed in cerebral cortex, hippocampus,
habenula, and cortical amygdala, with considerably less expression in
hypothalamic regions, as described previously (Kaneko and Fujiyama,
2002; Ziegler et al., 2002; Collin et al., 2003). Dual labeling with FG
revealed only occasional double-labeled cells throughout the
hypothalamus, with no double-labeling being observed in other
forebrain sites. These data show that VGluT1-positive neurons do not
constitute major sources of direct glutamatergic innervation to the
PVN, as suggested by the presence of few VGluT1-positive nerve fibers
in the PVN (Wittmann et al., 2005). These data also support the idea
that forebrain regions containing VGluT1-positive neurons (e.g.,
hippocampus and cerebral cortex) provide information to the PVN via
indirect circuits that utilize at least one intervening synapse (Herman
et al., 2003). In contrast, VGluT2 mRNA was highly expressed in the
habenula, as well as in numerous hypothalamic and thalamic nuclei, as
described previously (Ziegler et al., 2002; Lin et al., 2003; Hur and
Zaborszky, 2005; Barroso-Chinea et al., 2007). Dual labeling with FG
showed many double-labeled neurons throughout the forebrain,
particularly in the ventromedial hypothalamic nucleus, posterior
hypothalamic nucleus, lateral hypothalamic area, anterior
hypothalamic nucleus, dorsomedial hypothalamic nucleus,
paraventricular thalamic nucleus, and medial amygdala. These data
demonstrate that VGluT2-positive neurons contribute direct
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glutamatergic innervation to the PVN and its surround, and originate in
hypothalamic, thalamic, and amygdalar brain regions. This work is
consistent with earlier light and electron microscopy studies showing
that the PVN contains numerous VGluT2-positive nerve fibers that
contact corticotropin-releasing hormone and thyrotropin-releasing
hormone neurons (Wittmann et al., 2005; Ziegler et al., 2005), and
autoradiographic visualization of [3H]D-aspartate transport identifies
many of the same brain regions as potential sources of
glutamatergic/aspartatergic innervation to the PVN (Csaki et al.,
2000). Importantly, the proportion of FG labeled neurons that
colabeled for VGluT2 mRNA varied with the rostral-to-caudal extent of
the FG injection site within the PVN. When FG injections were targeted
to the anterior PVN, colocalization with VGluT2 was most common in
the ventromedial hypothalamic nucleus (≈25% of neurons). However,
when FG injections were targeted to the posterior PVN, colocalization
with VGluT2 was most common in the ventromedial hypothalamic
nucleus (≈80% of neurons), paraventricular thalamic nucleus (≈80%),
posterior hypothalamic nucleus (≈60%), medial amygdala (≈50%),
dorsomedial hypothalamic nucleus (≈40%), anterior hypothalamic
nucleus (≈25%), and lateral hypothalamic area (≈25%). Moreover,
anterograde PhaL tract tracing combined with VGluT2 immunolabeling
showed that 1) ventromedial nucleus-derived glutamatergic inputs
occur in both the anterior and posterior PVN; 2) posterior nucleusderived glutamatergic inputs occur predominantly in the posterior
PVN; and 3) medial preoptic nucleus-derived inputs to the PVN are not
glutamatergic, thereby independently corroborating the innervation
pattern. These data suggest that the extent of PVN innervation by
VGluT2-positive neurons varies between the anterior and posterior
portions of the nucleus and may have important implications for PVN
regulation (discussed further below).
In the present work, FG labeling from the PVN and its surround
identified numerous forebrain sites that contained PVN/surroundprojecting neurons (Table 2). This pattern of retrograde labeling from
the PVN mirrors that reported by others (Berk and Finkelstein, 1981;
Tribollet and Dreifuss, 1981; Sawchenko and Swanson, 1983;
Campeau and Watson, 2000), including the observation that
retrograde labeling in the medial amygdala is greater after injections
into the anterior PVN (Sawchenko and Swanson, 1983). In addition,
the PVN/surround-projecting forebrain regions identified in the present
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study are consistent with anterograde labeling studies. For instance,
the present data using PhaL tract tracing from the ventromedial,
posterior, and medial preoptic hypothalamic nuclei, taken together
with prior anterograde tract-tracing studies, demonstrate that the
anterior hypothalamic area and nucleus, dorsomedial hypothalamic
nucleus, lateral hypothalamic area, medial preoptic area and nucleus,
posterior hypothalamic nucleus, ventromedial hypothalamic nucleus,
paraventricular thalamic nucleus, medial amygdala, lateral septum,
substantia innominata, and zona incerta project fibers into the PVN
(Chiba and Murata, 1985; ter Horst and Luiten, 1986, 1987; Grove,
1988; Simerly and Swanson, 1988; Canteras et al., 1994; Risold et
al., 1994; Canteras et al., 1995; Vertes et al., 1995; Wagner et al.,
1995; Thompson et al., 1996; Risold and Swanson, 1997; Prewitt and
Herman, 1998) and/or peri-PVN regions (Ter Horst and Luiten, 1987;
Simerly and Swanson, 1988; Canteras et al., 1994, 1995; Risold et al.,
1994; Moga et al., 1995; Vertes et al., 1995; Risold and Swanson,
1997). Of note, a more limited number of FG-positive neurons were
observed in numerous other forebrain sites, including the subfornical
area and organum vasculosum of the lamina terminalis, which are
known to provide direct input to the PVN (Swanson and Lind, 1986;
Larsen and Mikkelsen, 1995; Duan et al., 2008; Shi et al., 2008). In
these particular regions the number of FG-positive cells was too low to
permit quantification of VGluT2 colocalization, possibly because the
relatively small size of these structures leads to infrequent sampling,
thereby providing fewer opportunities to visualize the cells. However,
we did observe several FG-positive cells in these regions that were
also positive for VGluT2 mRNA, suggesting that at least some of the
direct PVN projections from the subfornical organ and organum
vasculosum of the lamina terminalis are glutamatergic (Antunes et al.,
2006).
Moreover, the present study assessed potential differential
weighting of forebrain inputs to the anterior versus posterior portions
of the PVN. Following FG injections targeted to the anterior PVN, more
FG neurons were seen in the anterior hypothalamic area and nucleus
(central subdivision), arcuate nucleus, bed nucleus of the stria
terminalis, medial amygdala, median preoptic area, medial preoptic
area and nucleus, retrochiasmatic area, reticular thalamic nucleus,
suprachiasmatic nucleus, tuberal nucleus, and ventromedial
hypothalamic nucleus than with FG targeting to the posterior PVN,
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suggesting that these forebrain sites may provide relatively greater
inputs to the anterior (versus posterior) PVN. Anterograde PhaL tract
tracing from the ventromedial hypothalamic nucleus (Fig. 4), medial
preoptic nucleus (Fig. 6), and ventral medial amygdala (data not
shown) corroborates this idea, in that a higher density of PhaL fibers
derived from these structures were observed in the anterior versus
posterior PVN. In addition, others have shown that anterograde
labeling from the central subdivision of the anterior hypothalamic
nucleus (Risold et al., 1994), anterodorsal preoptic nucleus (Thompson
and Swanson, 2003), anteroventral preoptic nucleus (Thompson and
Swanson, 2003), medial preoptic nucleus (Thompson and Swanson,
2003), retrochiasmatic area (Ribeiro-Barbosa et al., 1999), ventral
medial amygdala (Prewitt and Herman, 1998), and ventromedial
hypothalamic nucleus (Canteras et al., 1994) yields more fibers in the
rostral versus caudal PVN, consistent with the retrograde labeling
observed presently. In contrast, similar numbers of FG neurons were
seen in the lateral hypothalamic area following anterior and posterior
PVN injections, suggesting that the extent of lateral hypothalamic area
input does not vary over the rostral-to-caudal extent of the nucleus.
Following FG targeted to the posterior PVN, larger numbers of FG
neurons were observed in the dorsomedial hypothalamic nucleus,
lateral preoptic area, lateral septum, posterior hypothalamic nucleus,
paraventricular thalamic nucleus, substantia innominata, and zona
incerta relative to anterior PVN injections, suggesting that the
posterior PVN and its surround may receive greater forebrain inputs
from these regions. Anterograde PhaL tract tracing from the posterior
hypothalamic nucleus (Fig. 5) revealed greater numbers of PhaLpositive fibers and boutons in the posterior (versus anterior) PVN,
supporting this pattern of innervation. However, anterograde labeling
from the lateral septum (data not shown) confirmed innervation
primarily of the PVN surround, with little entering the PVN itself (Risold
and Swanson, 1997), regardless of rostral-caudal level. FG-positive
neurons in the lateral septum following injection targeted to the PVN
probably resulted from the unavoidable spread of small amounts of FG
into the immediate vicinity of the PVN. For example, the lateral septum
projects to the reuniens nucleus of the thalamus, the zona incerta, and
the peri-PVN (Risold and Swanson, 1997). The spread of FG likely
occurred to a larger extent for the posterior PVN, where the shape of
the nucleus becomes laterally elongated such that the circular-shaped
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FG injection inevitably spreads further beyond the dorsal and/or
ventral boundaries of the nucleus. Notably, the collective innervation
pattern of the PVN seems to generally follow a spatial map, with
anterior and mid-level hypothalamic regions (anterior hypothalamic
area/nucleus, arcuate, median preoptic, medial preoptic,
retrochiasmatic, suprachiasmatic, tuberal, and ventromedial nuclei)
being identified as providing innervation preferentially to anterior-mid
PVN, and with mid-level and posterior hypothalamic regions
(dorsomedial and posterior nuclei) being identified as providing
innervation preferentially to mid-posterior PVN.
Anterograde labeling from the ventromedial, posterior, and
medial preoptic hypothalamic nuclei was combined with VGluT2
immunolabeling to determine 1) whether any observed colabeling of
FG and VGluT2 mRNA in these sites originated from the PVN itself
versus its immediate surround; and 2) whether the density of PVN
glutamatergic innervation from these sites varied across the rostral-tocaudal extent of the nucleus. Ventromedial nucleus-derived PhaL fibers
and boutons were present throughout the PVN, with the highest
density occurring in the anterior portion of the nucleus. Colabeling of
these PhaL fibers with VGluT2 immunoreactivity often occurred in the
PVN regardless of rostral-caudal level, suggesting that the
ventromedial nucleus is a source of PVN glutamatergic innervation
across the entire rostral-caudal extent of the nucleus. In contrast,
posterior hypothalamic nucleus-derived PhaL fibers and boutons
occurred with greatest frequency in the posterior PVN, as did colabeled
boutons for VGluT2 immunoreactivity, suggesting that the posterior
nucleus contributes glutamatergic innervation predominantly to the
posterior PVN. Medial preoptic nucleus-derived PhaL fibers and
boutons were most prevalent in the anterior PVN; however, colabeling
with VGluT2 was not observed regardless of rostral-caudal level,
suggesting that the medial preoptic nucleus uses other
neurotransmitters (e.g., GABA) and does not contribute glutamatergic
innervation to the PVN. Additional anterograde labeling studies will be
needed to confirm differential glutamatergic innervation of the PVN by
the other implicated forebrain regions. However, the collective work
supports the contention that glutamatergic innervation of the anteriorto-mid PVN and its surround is largely derived from the ventromedial
hypothalamic nucleus, whereas glutamatergic innervation of the mid-
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to-posterior PVN and its surround originates primarily in the
ventromedial, lateral, posterior, and dorsomedial hypothalamic nuclei.

Methodological considerations
The irregular geometries of the anterior and posterior PVN
present a significant barrier to retrograde tract-tracing studies. In the
current report we endeavored to interpret our data with respect to
both the present and previous anterograde tracing studies.
Nonetheless, we need to acknowledge that VGlut2 innervation of the
PVN proper (versus the PVN-surround) may be overestimated by the
retrograde labeling approach.
Immunohistochemical analyses of VGluT1 and VGluT2
immunoreactivity indicate nearly exclusive localization in terminals
(Herzog et al., 2001; Lin et al., 2003). This staining pattern prohibits
use of dual immunohistochemistry for colocalization of VGluT1 or
VGluT2 immunoreactivity in FG-positive neuronal cell bodies. The
double-labeling approach used here provides a reliable and proven
colocalization method for immunoreactivity and mRNA. However,
visualization of colocalization requires imaging silver grains in a thin
emulsion layer atop a 30 µm section (see Fig. 2 for example). We have
taken a conservative approach to identifying FG-positive neurons and
confirming mRNA colocalization, and may be missing colocalization in
FG-positive cells that are relatively deep within the tissue section or
whose morphology did not clearly resemble a cell body. In addition,
the fact that radioactive grains lie in an emulsion layer above cellular
sources probably causes us to miss radioactive sources lying deep in
the section. Thus, the current report likely under-estimates the
number of VGluT2/FG colocalized cells. Alternatively, it is possible that
VGluT mRNA expression is not a universal marker for glutamatergic
neurons. Previous studies establish VGluT1 and VGluT2 mRNA as
specific markers of the glutamatergic neurons (reviewed in Ziegler et
al., 2002; Takamori, 2006), but it is not yet known if they are
expressed in all glutamate neurons. Since our approach was consistent
across animals, the overall proportion of colocalized cells in a given
region can be compared between animals and injection sites.
Anterograde tract tracing with PhaL is a well-established
approach that labels the efferent projections from injection sites. PhaL
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injection sites are relatively small, providing increased anatomical
specificity at the expense of labeling the full extent of projecting
neurons. Thus, the abundance of PhaL-positive labeling in the PVN
following injection in the ventromedial, posterior, and medial preoptic
hypothalamic nuclei reflects labeling of only a subset of neurons in
these areas. Importantly, PhaL labels both the projecting fibers and
their terminals/boutons, providing the ability to coimmunolabel for
VGluT2 (which localizes only to glutamatergic nerve terminals). In this
manner, the proportion of PhaL-positive terminals that colabel with
VGluT2 can be visualized. However, since PhaL also labels projecting
fibers (versus VGluT2 immunoreactivity, which is only detected in
terminals), quantifying the relative amount of PhaL labeling that is
dual-labeled for VGluT2 cannot provide a meaningful representation of
the amount of PhaL-positive terminals that are colabeled. Hence, the
most appropriate manner to view this material is to gauge the relative
proportion of PhaL-positive terminals (excluding the fibers) that are
colabeled for VGluT2.
We should note that we have not included VGluT3 in our
analyses, as the present literature does not support it as a major
source of forebrain glutamatergic input to the PVN (Gras et al., 2002;
Schafer et al., 2002; Herzog et al., 2004). VGluT3 mRNA is present in
rodent brain at levels much below that of VGluT1 and VGluT2, and with
a much more limited forebrain distribution (e.g., scattered cells of
striatum, hippocampus, and neocortex) (Gras et al., 2002; Schafer et
al., 2002; Herzog et al., 2004). Moreover, VGluT3 mRNA expression
appears to largely occur in interneurons and/or brain regions that are
known to have little-to-no direct projections to the PVN (Gras et al.,
2002; Schafer et al., 2002; Herzog et al., 2004), thus the present
work focuses on VGluT1 and VGluT2 as the primary potential sources
of forebrain glutamatergic input to the PVN.

Functional considerations
An important consideration of the present work is the relative
abundance (and hence functional importance) of glutamatergic
innervation to the PVN. Clearly some sources of innervation (e.g.,
posterior hypothalamic nucleus, Fig. 5) provide a denser innervation to
the PVN-surround than to the PVN itself. The PVN surround contains

The Journal of Comparative Neurology, Vol. 519, No. 7 (May 2011): pg. 1301-1319. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

29

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

neurons that project into the PVN and regulate its function (Herman et
al., 2002), thereby providing an indirect means for PVN regulation by
the posterior hypothalamic nucleus. Additionally, the posterior
hypothalamic nucleus provides a more modest direct innervation to the
PVN itself, particularly to the middle and posterior portions. Given the
preponderance of multiple types of glutamate receptors throughout
the PVN, including the presence of NMDA-type receptors that function
to dramatically amplify glutamatergic signaling (Herman et al., 2000),
even a relatively modest number of glutamatergic inputs could
contribute significantly to neuronal signaling and PVN function.
Moreover, the methods employed invariably underestimate the full
extent of glutamatergic inputs (see Methodological considerations,
above), suggesting that the most appropriate interpretations are not
from the actual percentage of colabeling reported, but rather from
comparing the relative abundance among the various injection sites
(e.g., anterior versus posterior FG injection sites). Finally, the PVN
proper has a considerable neuronal density, whereas the surround is
rich in fibers. Thus, the relative amount of fiber input into the PVN
proper will likely appear lower than the surround, due to the space
occupied by the relatively large neuronal somata and their dendrites.
The observed rostral-to-caudal variations in the innervation of
the PVN and its surround may have important functional implications.
The PVN is comprised of connectionally distinct subregions, which vary
in position and orientation over the rostral-caudal extent of the
nucleus (reviewed in Sawchenko and Swanson, 1983). For example,
the anterior-to-middle portion of the PVN is enriched in thyrotropinreleasing hormone neurons (e.g., anterior, medial, and periventricular
parvocellular divisions; Lechan and Segerson, 1989), whereas the
middle-to-posterior PVN contains relatively larger amounts of
preautonomic neurons (Sawchenko and Swanson, 1983). Moreover,
the anterior magnocellular PVN primarily contains oxytocinergic
neurons, whereas the posterior PVN contains both oxytocinergic and
vasopressinergic magnocellular neurons (Sawchenko and Swanson,
1983). Based on this, one might predict that PVN functions mediated
by glutamatergic regulation of the anterior PVN are influenced largely
by the ventromedial hypothalamic nucleus, whereas functions
mediated by glutamatergic regulation of the posterior PVN are
predominantly influenced by the ventromedial hypothalamic nucleus,
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lateral hypothalamic area, posterior hypothalamic nucleus, and
dorsomedial hypothalamic nucleus.
In general, the anterior PVN region is lacking a significant
VGluT2 innervation from forebrain structures, with the exception of the
ventromedial hypothalamus. Regions projecting into the anterior PVN
are generally rich in GABAergic and peptidergic neurons (cf. Harlan et
al., 1987; Simerly and Swanson, 1987; Okamura et al., 1990),
suggesting that forebrain regulation of this region may be
accomplished primarily by these nonglutamatergic neuronal inputs.
The fact that the ventromedial nucleus is the primary source of
forebrain glutamate anterior PVN input is intriguing, given its role in
satiety mechanisms and glucose regulation (King, 2006). The anteriorto-mid PVN is enriched in neuroendocrine TRH cells that are implicated
in metabolic regulation (Lechan and Fekete, 2006), suggesting the
potential for glutamate-mediated activation of thyroid hormone
release. It is also important to consider that the anterior PVN contains
non-neuroendocrine neurons that innervate the lateral septum as well
as brainstem sites (Swanson and Kuypers, 1980; Risold and Swanson,
1997), providing an opportunity for metabolic information to be
communicated to limbic regulators of body temperature and brainstem
mediators of energy regulation.
The posterior PVN has by far the largest population of
preautonomic (i.e., brainstem and spinal cord) projecting neurons in
the nucleus (Sawchenko and Swanson, 1983). The more extensive
network of posterior PVN region-projecting VGlut2 neuron suggests a
prominent role of forebrain (particularly hypothalamic) glutamate in
autonomic functions of the PVN, which include regulation of heart rate,
blood pressure, and sympathetic nerve discharge (Badoer et al., 2003;
Kenney et al., 2003; Li et al., 2006; Freeman and Brooks, 2007). The
present data suggest a greater capacity for direct excitation of this
region by glutamate, consistent with rapid relay of homeostatic input
to autonomic effector systems.
The distribution of CRH neurons in the PVN straddles the
anterior and posterior divisions (Swanson et al., 1987). These data
suggest that the forebrain sources of input to CRH neurons may vary
across along the rostrocaudal extent of the nucleus, with the anterior
cell groups receiving VGluT2 innervation largely limited to the
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ventromedial hypothalamus, and the posterior regions receiving
significant input from a number of forebrain sources. Possible
rostrocaudal differences in input to CRH cell groups may reflect the
composite role of CRH in energy balance and stress regulation.
Overall, the anterior–posterior differences in innervation
patterns suggest that the relative role of forebrain glutamate
projections is differentially distributed with respect to endogenous PVN
cell populations. The data suggest a selective role for forebrain
glutamate in control of PVN output and, thereby, homeostatic
integration.
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